JPWO2021046549A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021046549A5 JPWO2021046549A5 JP2022514998A JP2022514998A JPWO2021046549A5 JP WO2021046549 A5 JPWO2021046549 A5 JP WO2021046549A5 JP 2022514998 A JP2022514998 A JP 2022514998A JP 2022514998 A JP2022514998 A JP 2022514998A JP WO2021046549 A5 JPWO2021046549 A5 JP WO2021046549A5
- Authority
- JP
- Japan
- Prior art keywords
- complex
- seq
- pharmaceutically acceptable
- conjugate
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (21)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962897036P | 2019-09-06 | 2019-09-06 | |
| US62/897,036 | 2019-09-06 | ||
| US201962941405P | 2019-11-27 | 2019-11-27 | |
| US62/941,405 | 2019-11-27 | ||
| US201962948143P | 2019-12-13 | 2019-12-13 | |
| US62/948,143 | 2019-12-13 | ||
| US202062959857P | 2020-01-10 | 2020-01-10 | |
| US62/959,857 | 2020-01-10 | ||
| US202062966500P | 2020-01-27 | 2020-01-27 | |
| US62/966,500 | 2020-01-27 | ||
| US202062970491P | 2020-02-05 | 2020-02-05 | |
| US62/970,491 | 2020-02-05 | ||
| US202062984705P | 2020-03-03 | 2020-03-03 | |
| US62/984,705 | 2020-03-03 | ||
| US202062988304P | 2020-03-11 | 2020-03-11 | |
| US62/988,304 | 2020-03-11 | ||
| US202063032488P | 2020-05-29 | 2020-05-29 | |
| US63/032,488 | 2020-05-29 | ||
| US202063062377P | 2020-08-06 | 2020-08-06 | |
| US63/062,377 | 2020-08-06 | ||
| PCT/US2020/049772 WO2021046549A1 (en) | 2019-09-06 | 2020-09-08 | Compositions and methods for the treatment of viral infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022546609A JP2022546609A (ja) | 2022-11-04 |
| JPWO2021046549A5 true JPWO2021046549A5 (zh) | 2023-09-15 |
Family
ID=74852729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022514998A Pending JP2022546609A (ja) | 2019-09-06 | 2020-09-08 | ウイルス感染症の治療のための組成物及び方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US20210220478A1 (zh) |
| EP (1) | EP4025256A4 (zh) |
| JP (1) | JP2022546609A (zh) |
| KR (1) | KR20220088527A (zh) |
| CN (1) | CN114980933A (zh) |
| AU (1) | AU2020342649A1 (zh) |
| BR (1) | BR112022004058A2 (zh) |
| CA (1) | CA3153359A1 (zh) |
| CL (1) | CL2022000531A1 (zh) |
| CO (1) | CO2022003078A2 (zh) |
| CR (1) | CR20220138A (zh) |
| EC (1) | ECSP22026797A (zh) |
| IL (1) | IL290792A (zh) |
| MX (1) | MX2022002728A (zh) |
| PE (1) | PE20221443A1 (zh) |
| TW (1) | TW202122117A (zh) |
| WO (1) | WO2021046549A1 (zh) |
| ZA (1) | ZA202203681B (zh) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113194983A (zh) | 2018-09-06 | 2021-07-30 | 奇达拉治疗公司 | 用于治疗病毒感染的组合物及方法 |
| TW202220698A (zh) | 2020-08-06 | 2022-06-01 | 美商席達拉醫療有限公司 | 蛋白質－藥物結合物之合成方法 |
| TW202220697A (zh) | 2020-08-06 | 2022-06-01 | 美商席達拉醫療有限公司 | 蛋白質－藥物結合物之合成方法 |
| CA3211494A1 (en) | 2021-03-11 | 2022-09-15 | Leslie W. Tari | Protein-drug conjugates for antiviral therapy |
| WO2023125806A1 (zh) * | 2021-12-30 | 2023-07-06 | 苏州爱科百发生物医药技术有限公司 | 用于预防和治疗病毒感染的偶联物及其用途 |
| WO2024010810A2 (en) * | 2022-07-05 | 2024-01-11 | Cidara Therapeutics, Inc. | Fc conjugates including an inhibitor of cd73 and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2271249C (en) | 1996-11-14 | 2010-07-20 | Biota Scientific Management Pty. Ltd. | Macromolecular neuraminidase-binding compounds |
| AUPP913999A0 (en) | 1999-03-12 | 1999-04-01 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| AUPR879701A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| NZ581395A (en) | 2007-05-14 | 2012-08-31 | Biogen Idec Inc | Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto |
| WO2010093706A2 (en) | 2009-02-10 | 2010-08-19 | The Scripps Research Institute | Chemically programmed vaccination |
| CN104777301B (zh) | 2010-05-10 | 2018-04-20 | 中央研究院 | 具有抗流感活性的扎那米韦膦酸酯同类物及流感病毒的奥司他韦易感性的测定 |
| TW201817745A (zh) | 2011-09-30 | 2018-05-16 | 日商中外製藥股份有限公司 | 具有促進抗原清除之ＦｃＲｎ結合域的治療性抗原結合分子 |
| SG11201507429TA (en) | 2013-03-15 | 2015-10-29 | Genentech Inc | Il-22 polypeptides and il-22 fc fusion proteins and methods of use |
| WO2017046625A1 (en) | 2015-06-25 | 2017-03-23 | Cube Biotech Gmbh | New chelators for affinity purification of recombinant proteins |
| US20230190950A1 (en) * | 2017-01-06 | 2023-06-22 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of bacterial infections |
| CN113194983A (zh) * | 2018-09-06 | 2021-07-30 | 奇达拉治疗公司 | 用于治疗病毒感染的组合物及方法 |
-
2020
- 2020-09-07 TW TW109130663A patent/TW202122117A/zh unknown
- 2020-09-08 PE PE2022000373A patent/PE20221443A1/es unknown
- 2020-09-08 KR KR1020227011190A patent/KR20220088527A/ko active Search and Examination
- 2020-09-08 JP JP2022514998A patent/JP2022546609A/ja active Pending
- 2020-09-08 WO PCT/US2020/049772 patent/WO2021046549A1/en active Application Filing
- 2020-09-08 BR BR112022004058A patent/BR112022004058A2/pt unknown
- 2020-09-08 CR CR20220138A patent/CR20220138A/es unknown
- 2020-09-08 EP EP20860243.3A patent/EP4025256A4/en active Pending
- 2020-09-08 AU AU2020342649A patent/AU2020342649A1/en active Pending
- 2020-09-08 CN CN202080077368.1A patent/CN114980933A/zh active Pending
- 2020-09-08 CA CA3153359A patent/CA3153359A1/en active Pending
- 2020-09-08 MX MX2022002728A patent/MX2022002728A/es unknown
-
2021
- 2021-03-05 US US17/194,093 patent/US20210220478A1/en not_active Abandoned
- 2021-04-21 US US17/236,745 patent/US11510992B1/en active Active
-
2022
- 2022-02-22 IL IL290792A patent/IL290792A/en unknown
- 2022-03-03 CL CL2022000531A patent/CL2022000531A1/es unknown
- 2022-03-17 CO CONC2022/0003078A patent/CO2022003078A2/es unknown
- 2022-03-30 ZA ZA2022/03681A patent/ZA202203681B/en unknown
- 2022-04-05 EC ECSENADI202226797A patent/ECSP22026797A/es unknown
- 2022-08-15 US US17/887,776 patent/US20230398226A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016153410A5 (zh) | ||
| JP2006521361A5 (zh) | ||
| DK2806896T3 (en) | Chitosan covalently bound to small molecule integrin antagonist for targeted delivery | |
| RU2008126305A (ru) | Новый пептид | |
| WO2003066069A1 (en) | Polymers for delivering peptides and small molecules in vivo | |
| JP2021536483A (ja) | ウイルス感染症の治療のための組成物及び方法 | |
| JP2011529948A5 (zh) | ||
| RU2015101332A (ru) | Новые реагенты для конъюгации | |
| JP2015529678A5 (zh) | ||
| JP2013500304A5 (zh) | ||
| JP2019524687A5 (zh) | ||
| JPWO2021046549A5 (zh) | ||
| RU2011123700A (ru) | Нонапептид с противоопухолевой активностью | |
| JP2023184757A5 (zh) | ||
| CA2811957A1 (en) | Soluble tlr2 moiety for use in the treatment or prevention of respiratory conditions associated with infectious agents | |
| JP2023129495A5 (zh) | ||
| JP2018531287A5 (zh) | ||
| JPWO2021019243A5 (zh) | ||
| JP2014525939A5 (zh) | ||
| RU2014111179A (ru) | КОНЪЮГАТЫ ИНТЕРФЕРОНА λ1 И ПОЛИЭТИЛЕНГЛИКОЛЯ | |
| JP2835773B2 (ja) | ポリアミン誘導体を使用して、細胞で媒介される免疫を増強する方法 | |
| JPWO2020051498A5 (zh) | ||
| TW200800272A (en) | Drug-polymer conjugates | |
| JP2010523632A5 (zh) | ||
| JP2020530453A5 (zh) |